Sanofi buys US biopharma group Blueprint in $9.1 billion deal

Technology & Startups

Sanofi buys US biopharma group Blueprint in $9.1 billion deal

June 2, 2025

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical company specializing in systemic ...

Tag: biopharmaceutical company

Sanofi buys US biopharma group Blueprint in $9.1 billion deal

Family calls for change after B.C. nurse dies by suicide after attacks on the job

Product reduces TPH levels to non-hazardous status

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

Police ID man who died after Corso Italia fight

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

Trump ‘looks forward’ to White House meeting with Biden

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Joe Rogan’s blunt reply shuts down Bernie Sanders’ attack on Musk todayheadline

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines todayheadline

Ravi Agarwal gets one year extension as CBDT chairman todayheadline

Brain Scan Marker Helps Classify Alzheimer’s Risk todayheadline

Recent News

Joe Rogan’s blunt reply shuts down Bernie Sanders’ attack on Musk todayheadline

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines todayheadline

Ravi Agarwal gets one year extension as CBDT chairman todayheadline

Brain Scan Marker Helps Classify Alzheimer’s Risk todayheadline

Browse by Category

Recent News

Joe Rogan’s blunt reply shuts down Bernie Sanders’ attack on Musk todayheadline

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines todayheadline